MN
Murphy Nicole
Responsable des Opérations Pharmaceutiques et de la Technologie
OtherF
内部人交易记录
高级管理人员基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Murphy Nicole, Responsable des Opérations Pharmaceutiques et de la Technologie. Insider active across 1 company, notably BIOGEN INC.. In total, 18 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €493. History available since 12 February 2022. The latest transaction was disclosed on 12 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Murphy Nicole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
3 股@ US$195.0354.3% 占其流量Common StockSEC:0000875045-26-000033:0
2,102 股0Common StockSEC:0000875045-26-000022:0
2,272 股0Common StockSEC:0001127602-25-004461:0
2,102 股0Common StockSEC:0001127602-25-003957:0
240 股0Common StockSEC:0001127602-24-012405:0
856 股0Common StockSEC:0001127602-24-006213:0
2,272 股0Common StockSEC:0001127602-24-004800:0
2,101 股0Common StockSEC:0001127602-24-004304:0
239 股0Common StockSEC:0001127602-23-012361:0
480 股0Common StockSEC:0001127602-23-006524:0
2,271 股0Common StockSEC:0001127602-23-005268:0
1,340 股0Common StockSEC:0001127602-23-002483:0
39 股@ US$298.90100.0% 占其流量Common StockSEC:0001127602-22-026992:1
131 股0Common StockSEC:0001127602-22-026992:0
255 股0Common StockSEC:0001127602-22-020415:0
239 股Common StockSEC:0001127602-22-011610:0
371 股0Common StockSEC:0001127602-22-006278:0
263 股0Common StockSEC:0001127602-22-004984:0
About Murphy Nicole
Murphy Nicole is Head of Pharm Ops and Tech at BIOGEN INC. She has 18 filings in total, and across the 18 sampled filings, buy transactions amount to EUR 493 and sell transactions to EUR 0, over the period from 2022-02-15 to 2026-02-17. The most common transaction nature is option exercise.